...
ARGXLARGE

argenx SE

HealthcareBiotechnology
$766.92
$0.05(-0.60%)
52W$510.06
$934.62
Updated Mar 2, 12:00 AM
RSI34
RS Rating58/99
Beta0.44
Volatility33%
F-Score3/9
Mkt Cap$47.5B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

argenx SE is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 58), indicating performance broadly in line with the market. Earnings growth of 13% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
58
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.44
vs S&P 500
LOW VOL
52W Position
61%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$827.33
50 SMA > 100 SMA$845.28
100 SMA > 150 SMA$798.35
150 SMA > 200 SMA$740.35

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$827.40-7.31%BELOW
50 SMA$827.33-7.30%BELOW
100 SMA$845.28-9.27%BELOW
150 SMA$798.35-3.94%BELOW
200 SMA$740.35+3.59%ABOVE

Price Performance

1D-0.6%
1W-7.2%
1M-9.4%
3M-15.9%
6M+8.9%
YTD-8.7%
1Y+22.8%
3Y+28.0%
52-Week Trading Range61% from low
$766.92
52W Low$510.06
52W High$934.62

Technical Indicators

RSI (14)BEARISH
33.9
305070
VCP ScoreCOOL
5/10
Base depth: 22.9%

Risk Profile

Beta
0.44
52W Vol
33%
ATR
$24.07
Max DD (1Y)
-19%

Volume Analysis

Today
766
50D Avg
300.6K
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q4'23+63%
$-2.95
Q2'24+93%
$-0.55
Q4'24+364%
$12.20
Q2'25+414%
$6.37
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+85.39%
5 Years:+94.61%
3 Years:+63.92%
TTM:+335.20%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+167.07%

Stock Price CAGR

10 Years:+42.00%
5 Years:+17.63%
3 Years:+27.96%
1 Year:+22.77%

Return on Equity

10Y Avg:-20.4%
5Y Avg:-15.9%
3Y Avg:-5.9%
Last Year:15.1%

Key Metrics

Market Cap$47.5B
Gross Margin89.6%
Net Margin38.0%
Piotroski F-Score3/9

Frequently Asked Questions

Is ARGX in an uptrend right now?

ARGX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ARGX overbought or oversold?

ARGX's RSI (14) is 34. The stock is in neutral territory, neither overbought nor oversold.

Is ARGX outperforming the market?

ARGX has a Relative Strength (RS) Rating of 58 out of 99. ARGX is performing about average compared to the market.

Where is ARGX in its 52-week range?

ARGX is trading at $766.92, which is 82% of its 52-week high ($934.62) and 61% above its 52-week low ($510.06).

How volatile is ARGX?

ARGX has a Beta of 0.44 and 52-week volatility of 33%. It's less volatile than the S&P 500 - generally more stable.